Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wanpu Yan

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|September 11, 2025
[Application Value of Neoadjuvant Targeted Therapy in Patients with EGFR-mutant 
Resectable Lung Adenocarcinoma]Shijie Huang, Mengying Fan, Kaiming Peng, et al.
Journal of Thoracic Disease|May 22, 2025
Prognosis and relapse patterns in patients with non-small cell lung cancer with pathologic complete response after neoadjuvant immunochemotherapyYifan Fang, Wanpu Yan, Ze-Rui Zhao, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 4, 2026
Surgical management of the primary tumor in stage M1a-IVA Non-Small Cell Lung CancerYifan Fang, Mengying Fan, Hanxiao Chen, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|March 29, 2018
[Analysis of Prolonged Hospitalizations (Longer than 7 days): 115 Lung Cancer 
Patients after Video Assistant Thoracic Surgery (VATS)]Liang Dai, Xiaozheng Kang, Wanpu Yan, et al.
Journal of Thoracic Disease|September 15, 2025
Effects of nutritional support during neoadjuvant therapy on perioperative outcome in esophageal cancer: a real-world cohort studyYongbo Yang, Yan He, Wan Wei, et al.
Translational Lung Cancer Research|January 20, 2025
Osimertinib as a neoadjuvant therapy in resectable EGFR-mutant non-small cell lung cancer: a real-world, multicenter retrospective studyJialong Li, Youyu Wang, Zerui Zhao, et al.
Theranostics|May 23, 2017
Cross-Platform Comparison of Four Leading Technologies for Detecting <i>EGFR</i> Mutations in Circulating Tumor DNA from Non-Small Cell Lung Carcinoma Patient PlasmaTing Xu, Xiaozheng Kang, Xiaofang You, et al.
Translational Lung Cancer Research|August 13, 2025
Comparative efficacy of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) monotherapy versus combined EGFR-TKI and chemotherapy in resectable EGFR-mutant non-small cell lung cancer: a real-world multicenter retrospective studyMengying Fan, Zerui Zhao, Wanpu Yan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2022
Adebrelimab (SHR-1316) in Combination With Chemotherapy as Perioperative Treatment in Patients With Resectable Stage II to III NSCLCs: An Open-Label, Multicenter, Phase 1b TrialWanpu Yan, Wen-Zhao Zhong, Yan-Hui Liu, et al.
The Annals of Thoracic Surgery|May 29, 2018
Postoperative Radiotherapy for Surgically Resected ypN2 Non-Small Cell Lung CancerWhitney S Brandt, Wanpu Yan, Jonathan E Leeman, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|September 11, 2025
[Application Value of Neoadjuvant Targeted Therapy in Patients with EGFR-mutant 
Resectable Lung Adenocarcinoma]Shijie Huang, Mengying Fan, Kaiming Peng, et al.
Journal of Thoracic Disease|May 22, 2025
Prognosis and relapse patterns in patients with non-small cell lung cancer with pathologic complete response after neoadjuvant immunochemotherapyYifan Fang, Wanpu Yan, Ze-Rui Zhao, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 4, 2026
Surgical management of the primary tumor in stage M1a-IVA Non-Small Cell Lung CancerYifan Fang, Mengying Fan, Hanxiao Chen, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|March 29, 2018
[Analysis of Prolonged Hospitalizations (Longer than 7 days): 115 Lung Cancer 
Patients after Video Assistant Thoracic Surgery (VATS)]Liang Dai, Xiaozheng Kang, Wanpu Yan, et al.
Journal of Thoracic Disease|September 15, 2025
Effects of nutritional support during neoadjuvant therapy on perioperative outcome in esophageal cancer: a real-world cohort studyYongbo Yang, Yan He, Wan Wei, et al.
Translational Lung Cancer Research|January 20, 2025
Osimertinib as a neoadjuvant therapy in resectable EGFR-mutant non-small cell lung cancer: a real-world, multicenter retrospective studyJialong Li, Youyu Wang, Zerui Zhao, et al.
Theranostics|May 23, 2017
Cross-Platform Comparison of Four Leading Technologies for Detecting <i>EGFR</i> Mutations in Circulating Tumor DNA from Non-Small Cell Lung Carcinoma Patient PlasmaTing Xu, Xiaozheng Kang, Xiaofang You, et al.
Translational Lung Cancer Research|August 13, 2025
Comparative efficacy of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) monotherapy versus combined EGFR-TKI and chemotherapy in resectable EGFR-mutant non-small cell lung cancer: a real-world multicenter retrospective studyMengying Fan, Zerui Zhao, Wanpu Yan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 3, 2022
Adebrelimab (SHR-1316) in Combination With Chemotherapy as Perioperative Treatment in Patients With Resectable Stage II to III NSCLCs: An Open-Label, Multicenter, Phase 1b TrialWanpu Yan, Wen-Zhao Zhong, Yan-Hui Liu, et al.
The Annals of Thoracic Surgery|May 29, 2018
Postoperative Radiotherapy for Surgically Resected ypN2 Non-Small Cell Lung CancerWhitney S Brandt, Wanpu Yan, Jonathan E Leeman, et al.
Pageof 5